Primary Hepatic Neuroendocrine Tumours of Liver- a Rarity: Single Centre Analysis of 13 Patients

Overview

Journal Ann Hepatobiliary Pancreat Surg

Date 2020 Mar 18

PMID 32181424

Citations 5

Authors

Amir Parray

Shraddha Patkar

Mahesh Goel

Affiliations

Soon will be listed here.

Abstract

Backgrounds/aims: Primary hepatic neuroendocrine tumours (PHNETs) are a rarity and this rarity imparts management complexities.

Methods: A retrospective analysis of prospectively maintained liver database from 2009 to 2018 was performed and patients with PHNETs were identified and studied for clinical, imaging and pathological features, surgical outcomes, disease free and overall survival.

Results: Thirteen patients of PHNET were identified following rigorous investigational protocols, which constituted 0.6% of all liver tumours (2095) in our series. The median age of patients was 50 years (14-65), with male to female ratio of 9:4. Eight patients (62%) underwent hepatic resections as primary treatment, while 5 (38%) patients received peptide receptor radiotherapy, trans-arterial chemotherapy, trans-arterial radiotherapy or a combination of these. In the surgical group at a median follow up of 36 months (range 5-114 months), 4 (50%) patients were alive without disease and disease free survival was 20 months. Median OS in surgical group was 47 months (40-53, 95% confidence interval) that was better but not statistically significant from that of non-surgical treatment group (36 months).

Conclusions: PHNETs are rare tumours that require multidisciplinary treatment approach. Liver directed surgery centred management leads to better clinical outcomes in these selected patients.

Citing Articles

Rare and lacking typical clinical symptoms of liver tumors: Four case reports.

Zhao Y, Bie Y, Zhang G, Feng Y, Wang F World J Gastrointest Oncol. 2024; 16(10):4264-4273.

PMID: 39473954 PMC: 11514678. DOI: 10.4251/wjgo.v16.i10.4264.

Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.

Komiyama S, Okusaka T, Maruki Y, Ohba A, Nagashio Y, Kondo S Intern Med. 2023; 63(7):891-901.

PMID: 37612088 PMC: 11045373. DOI: 10.2169/internalmedicine.2016-23.

Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.

Lin J, Li X, Ding X, Chen Z, Wu Y, Zhao K Front Med (Lausanne). 2022; 9:960235.

PMID: 36425110 PMC: 9679223. DOI: 10.3389/fmed.2022.960235.

Diagnostic problem of Primary Hepatic Neuroendocrine Tumor in 18-year-old woman: A case report.

Andriani J, Budipramana V, Sadikin C Int J Surg Case Rep. 2022; 95:107224.

PMID: 35605353 PMC: 9127590. DOI: 10.1016/j.ijscr.2022.107224.

Primary hepatic neuroendocrine tumour masquerading as a giant haemangioma: an unusual presentation of a rare disease.

Almas T, Inayat F, Ehtesham M, Khan M BMJ Case Rep. 2020; 13(9).

PMID: 32900712 PMC: 7481094. DOI: 10.1136/bcr-2020-236153.

References

Chen Z, Xiao H, Ramchandra P, Huang H . Imaging and pathological features of primary hepatic neuroendocrine carcinoma: An analysis of nine cases and review of the literature. Oncol Lett. 2014; 7(4):956-962. PMC: 3961293. DOI: 10.3892/ol.2014.1844. View

Shetty P, Baliga S, Balaiah K, Gnana P . Primary hepatic neuroendocrine tumor: an unusual cystic presentation. Indian J Pathol Microbiol. 2010; 53(4):760-2. DOI: 10.4103/0377-4929.72078. View

Knox C, Anderson C, Lamps L, Adkins R, Pinson C . Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003; 10(10):1171-5. DOI: 10.1245/aso.2003.04.533. View

Caplin M, Buscombe J, Hilson A, Jones A, Watkinson A, Burroughs A . Carcinoid tumour. Lancet. 1998; 352(9130):799-805. DOI: 10.1016/S0140-6736(98)02286-7. View

Yang J, Kan Y, Ge B, Yuan L, Li C, Zhao W . Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis. Acta Radiol. 2013; 55(4):389-98. DOI: 10.1177/0284185113496679. View

Huang Y, Xu F, Yang J, Huang B . Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. Hepatobiliary Pancreat Dis Int. 2010; 9(1):44-8. View

Yalav O, Ulku A, Akcam T, Demiryurek H, Doran F . Primary hepatic neuroendocrine tumor: Five cases with different preoperative diagnoses. Turk J Gastroenterol. 2012; 23(3):272-8. DOI: 10.4318/tjg.2012.0465. View

Iimuro Y, Deguchi Y, Ueda Y, Tanaka A, Iwasa Y, Ishihara M . Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol. 2002; 17(10):1119-24. DOI: 10.1046/j.1440-1746.2002.02663.x. View

Inzani F, Petrone G, Rindi G . The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia. Endocrinol Metab Clin North Am. 2018; 47(3):463-470. DOI: 10.1016/j.ecl.2018.04.008. View

10.

Lin C, Lai C, Hsu C, Hsu C, Hsieh P, Hung K . Primary hepatic carcinoid tumor: a case report and review of the literature. Cases J. 2009; 2(1):90. PMC: 2654436. DOI: 10.1186/1757-1626-2-90. View

11.

IWAO M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y . Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit. 2001; 7(4):746-50. View

12.

Hwang S, Lee Y, Lee S, Kim C, Kim K, Ahn C . Surgical treatment of primary neuroendocrine tumors of the liver. J Gastrointest Surg. 2007; 12(4):725-30. DOI: 10.1007/s11605-007-0418-2. View

13.

Park C, Chung J, Jang S, Chung M, Bang S, Park S . Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. J Gastroenterol Hepatol. 2012; 27(8):1306-11. DOI: 10.1111/j.1440-1746.2012.07117.x. View

14.

Wang L, An S, Wu J . Diagnosis and therapy of primary hepatic neuroendocrine carcinoma: clinical analysis of 10 cases. Asian Pac J Cancer Prev. 2014; 15(6):2541-6. DOI: 10.7314/apjcp.2014.15.6.2541. View

15.

Krohn M, Grieser C, Weichert W, Pascher A, Denecke T . Well-differentiated neuroendocrine carcinoma mimicking an echinococcus cyst of the liver in CT-MRI findings with hepatocyte specific contrast material. J Gastrointestin Liver Dis. 2011; 20(4):439-42. View

16.

Andreola S, Lombardi L, Audisio R, Mazzaferro V, Koukouras D, Doci R . A clinicopathologic study of primary hepatic carcinoid tumors. Cancer. 1990; 65(5):1211-8. DOI: 10.1002/1097-0142(19900301)65:5<1211::aid-cncr2820650530>3.0.co;2-m. View

17.

Tohyama T, Matsui K, Kitagawa K . Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up. Intern Med. 2005; 44(9):958-62. DOI: 10.2169/internalmedicine.44.958. View

18.

Yasoshima H, Uematsu K, Sakurai K, Ueno Y, Hori K, Kanazawa N . Primary hepatic carcinoid tumor. Acta Pathol Jpn. 1993; 43(12):783-9. DOI: 10.1111/j.1440-1827.1993.tb02567.x. View

19.

Gravante G, de Liguori Carino N, Overton J, Manzia T, Orlando G . Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg. 2008; 25(5):364-8. DOI: 10.1159/000167021. View

20.

van der Hoef M, Crook D, Marincek B, Weishaupt D . Primary neuroendocrine tumors of the liver: MRI features in two cases. Abdom Imaging. 2004; 29(1):77-81. DOI: 10.1007/s00261-003-0064-4. View